Microbial Fermentation APIs Market (Updated Version Available)

Active pharmaceutical ingredients or APIs can be defined as the chemicals used to manufacture pharmaceutical drugs. They are generally manufactured through a variety of processes that include chemical synthesis, fermentation processes, recombinant DNA, etc.

Microbial fermentation APIs are secondary metabolites produced by micro-organisms such as fungi and actinomycetes. The micro-organisms are capable of converting inexpensive carbon sources (starch, glucose, sucrose, etc.) and nitrogen sources (soybean flour, cotton-seed flour, peptone, etc.) into highly valuable API's or key intermediates (such as amino acids, vitamines, antibiotics) in liquid or solid media under certain growth conditions (nutrients, temperature, PH, oxygen supply).

Microorganisms that are typically used within the pharmaceutical industry include: prokaryotes such as Bacteria (e.g. Escherichia coli, Staphylococcus aureus) and Streptomycetes (e.g. Streptomyces spp, Actinomyces spp), eukaryotes such as Filamentous Fungi (e.g., Nigrospora spp, Aspergillus spp,) and Yeast (e.g. Saccharomyces cereviciae, Pichia pastoris).

With developed pharmaceuticals industry, Europe, USA and Japan are the major consumption markets of microbial fermentation APIs. These international pharmaceuticals giants generally purchase APIs from Asia, especially China and India.
China is the emerging consumption market of microbial fermentation APIs and it is also the largest supplier. In the market of antibiotics and vitamin, China have occupied market share of more than half. With foreign based plants and local manufacturers, India is another major supplier of APIs.
Antibiotics enjoyed the largest market share of microbial fermentation APIs, and China is the largest supplier with production of about 150 K MT. Amino acids are another important parts of microbial fermentation APIs market. Among these amino acids, the amount of glutamic acid and l-lysine are at most.

The report offers detailed coverage of Microbial Fermentation APIs industry and main market trends. The market research includes historical and forecast market data, demand, application details, price trends, and company shares of the leading Microbial Fermentation APIs by geography. The report splits the market size, by volume and value, on the basis of application type and geography.

The report forecast global Microbial Fermentation APIs market to grow to reach xxx Million USD in 2020 with a CAGR of xx% during the period 2021-2025.

First, this report covers the present status and the future prospects of the global Microbial Fermentation APIs market for 2015-2025.
And in this report, we analyze global market from 5 geographies: Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia], Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland], North America[United States, Canada, Mexico], Middle East & Africa[GCC, North Africa, South Africa], South America[Brazil, Argentina, Columbia, Chile, Peru].

Key Companies
Merck
Ajinomoto
HGPF
Huaxing
North China Pharmaceutical
Topfond
DSM
Tianyao
CSPC Pharma
Northeast Pharm
Lukang Pharmaceutical
Luwei Pharmaceutical
Jiangshan (DSM)

At the same time, we classify Microbial Fermentation APIs according to the type, application by geography. More importantly, the report includes major countries market based on the type and application.

Market Segment as follows:
Market by Order Type
Antibiotics
Amino acids
Vitamin
Nucleotide
Organic acid
Alcohol
Biological products
Hormone
Market by Application
Hospitals
Research & Academic Laboratories
Pharmaceutical & Biotechnology Companies

By Region
Asia-Pacific[China, Southeast Asia, India, Japan, Korea, Western Asia]
Europe[Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
North America[United States, Canada, Mexico]
Middle East & Africa[GCC, North Africa, South Africa]
South America[Brazil, Argentina, Columbia, Chile, Peru]

The research provides answers to the following key questions:
• What is the estimated growth rate and market share and size of the Microbial Fermentation APIs market for the forecast period 2021 - 2025?
• What are the driving forces in the Microbial Fermentation APIs market for the forecast period 2021 - 2025?
• Who are the prominent market players and how have they gained a competitive edge over other competitors?
• What are the market trends influencing the progress of the Microbial Fermentation APIs industry worldwide?
• What are the major challenges and threats restricting the progress of the industry?
• What opportunities does the market hold for the prominent market players?